Przejdź do zawartości
Merck
Wszystkie zdjęcia(2)

Dokumenty

CAS9MRNA

Sigma-Aldrich

Cas9 mRNA

Synonim(y):

CRISPR Cas9 mRNA

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych
Wszystkie zdjęcia(2)

About This Item

Kod UNSPSC:
41106609
NACRES:
NA.51

opakowanie

vial of 50 μL

stężenie

500 ng/μL

Warunki transportu

dry ice

temp. przechowywania

−70°C

Powiązane kategorie

Opis ogólny

Cas9 mRNA generated through in-vitro transcription which has been capped and polyA-tailed. This mRNA should be used in conjunction with purified guideRNA. The use of RNA vs. plasmid constructs avoids complications with promoter-embryo compatibility as well as the possibility of random integration of nuclease and gRNA-expressing plasmids into the host animal genome.

Zastosowanie

Functional Genomics/Transgenic Applications
  • Creation of gene knockouts in transgenic applications
  • Creation of knock-in animals with promoters, fusion tags or reporters integrated into endogenous genes

Cechy i korzyści

RNA ready to use in transgenic applications. Must be used in conjunction with a purified guideRNA sequence to mediate a site specific double strand break in the DNA.

Komponenty

1 vial containing 25ug of Cas9 mRNA.

Please note, product does not contain guideRNA sequence. This must be purchased separately through the Custom CRISPR product tab.

Zasada

CRISPR/Cas systems are employed by bacteria and archaea as a defense against invading viruses and plasmids. Recently, the type II CRISPR/Cas system from the bacterium Streptococcus pyogenes has been engineered to function in eukaryotic systems using two molecular components: a single Cas9 protein and a non-coding guide RNA (gRNA). The Cas9 endonuclease can be programmed with a single gRNA, directing a DNA double-strand break (DSB) at a desired genomic location. Similar to DSBs induced by zinc finger nucleases (ZFNs), the cell then activates endogenous DNA repair processes, either non-homologous end joining (NHEJ) or homology-directed repair (HDR), to heal the targeted DSB.

Postać fizyczna

Sigma Cas9 mRNA is supplied at a concentration of 500 ng/ul (50 ul Cas9 mRNA, capped and polyA-tailed)

Uwaga dotycząca przygotowania

While Sigma implements the same high quality RNA synthesis procedures that have been successful in many mRNA-based ZFN transgenic projects, we highly recommend centrifuging your final, concentration-adjusted CRISPR RNA samples immediately prior to microinjection to ensure all particulate material has been removed which may result in clogging of microinjection needles.

Inne uwagi

Must be used in conjunction with the RNA format of a guideRNA sequence in order to mediate a double strand break in the DNA.
Typical microinjection concentrations used in the literature are in the ranges of 20-200 ng/ul for Cas9 mRNA and 10-50 ng/ul for gRNA.
While Sigma CRISPR RNA was not developed for robust application to cell culture, we have seen some success in detecting CEL-I activity using RNA-only formats for both CRISPR nucleases and paired nickases.  RNA-only delivery formats may be favorable for cell types which are sensitive to double stranded DNA such a dendritic cells or when promoter-cell incompatibilities exist.

Informacje prawne

CRISPR Use License Agreement

Kod klasy składowania

12 - Non Combustible Liquids

Klasa zagrożenia wodnego (WGK)

WGK 1

Temperatura zapłonu (°F)

Not applicable

Temperatura zapłonu (°C)

Not applicable

Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Marc-Olivier Turgeon et al.
Endocrinology, 158(4), 815-830 (2017-03-23)
Loss-of-function mutations in the X-linked immunoglobulin superfamily, member 1 (IGSF1) gene cause central hypothyroidism. IGSF1 is a transmembrane glycoprotein of unknown function expressed in thyrotropin (TSH)-producing thyrotrope cells of the anterior pituitary gland. The protein is cotranslationally cleaved, with only

Protokoły

CRISPR Cas 9 Nuclease RNA-guided Genome Editing

Learn about CRISPR Cas9, what it is and how it works. CRISPR is a new, affordable genome editing tool enabling access to genome editing for all.

Edycja genomu za pomocą nukleazy RNA CRISPR Cas 9

Dowiedz się więcej o CRISPR Cas9, czym jest i jak działa. CRISPR to nowe, przystępne cenowo narzędzie do edycji genomu, umożliwiające dostęp do edycji genomu dla wszystkich.

Powiązane treści

Gene Expression & Silencing

Sigma-Aldrich® Advanced Genomics is the leading provider of gene editing and silencing technologies including CRISPR, Cas9, synthetic guide RNA (sgRNA), and Zinc Finger Nuclease (ZFN).

Ekspresja i wyciszanie genów

Sigma-Aldrich® Advanced Genomics jest wiodącym dostawcą technologii edycji i wyciszania genów, w tym CRISPR, Cas9, syntetycznego RNA prowadzącego (sgRNA) i Zinc Finger Nuclease (ZFN).

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej